12 ° C
Light Rain
Breaking News

28 new Covid cases on 19 Jan. brings total to 1,240: 36 hospitalised: 16 resident + 10 in ICU: 4 resident, 114 home monitored, 1,036 recoveries, 9 deaths

CSM signs finance deal with coral molecule maker

CSM signs finance deal with coral molecule maker

By Cassandra Tanti - January 11, 2021

The Monaco Scientific Centre has become the first public establishment in Monaco to take an interest in a private company, signing a financial agreement with local startup Coraliotech, which recreates coral molecules to be used in health products.

The finance deal was signed between the Monaco Scientific Centre (CSM) and Coraliotech on Monday 11th January. It is the culmination of a collaboration that began between the CSM and Dr. Rachid Benchaouir, Founder and CEO of Coraliotech, in 2014.

Dr. Benchaouir had been carrying out joint research with the Departments of Marine Biology and Medical Biology, studying genetic diseases and DNA sequencing of corals. He discovered a coral molecule that can be used in the development of pharmacological and cosmetic products, for both innovative and sustainable purposes. The molecule helps protect skin cells against ultraviolet radiation and particularly toxic chemical agents.

These properties have been patented and the CSM is co-owner.

Mr. Benchaouir created Coraliotech with the support of the CSM, and the Monegasque marine biotechnology startup has been part of the MonacoTech incubator since the end of 2017. Its objective is to produce, promote and market products of interest to human health from these marine organisms, which have been recreated in a laboratory using coral DNA.

“The entry of CSM into the capital of Coraliotech demonstrates that science and the development of new applications are closely linked and makes it possible to capitalise on the benefits of this joint patent through the marketing of patented products or operating licenses,” said the government in a press statement. “With this signature… the CSM becomes the first Monegasque public establishment to enter the capital of a private company.”


Photo of Dr R. Benchaouir and Pr P. Rampal signing the financial agreement, by Michaël Alesi/Government Communication Department



Previous articleNewly-approved Moderna jab arriving in Nice
Next articleHealth authorities report new coronavirus victim


January 15, 2021 | Business & Finance

What will the EU’s recovery look like?

Stephanie Horsman

The European Union is about to roll out its biggest stimulus package ever seen as focus turns from Covid testing and vaccination to economic recovery.

January 14, 2021 | Business & Finance

How many workers in Monaco are female?

Stephanie Horsman

Women made up 41% of the workforce in large companies in 2019 and the majority were French. These are just some of the findings to come out of the latest report by IMSEE.

January 14, 2021 | Business & Finance

Sportel cancelled

Stephanie Horsman

As a resurgence of the Covid pandemic brings continued uncertainty for the coming months, organisers of Sportel Winter have given up trying to pursue their February event at the Grimaldi Forum.

January 12, 2021 | Business & Finance

What is the Blue Fund?

Cassandra Tanti

Businesses looking for a digital overhaul will have up to 70% of the project paid for by the government in a recovery package designed to help companies reach their digital potential.